{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:44:40Z","timestamp":1773297880284,"version":"3.50.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.euroneuro.2005.05.002","type":"journal-article","created":{"date-parts":[[2005,6,15]],"date-time":"2005-06-15T07:43:59Z","timestamp":1118821439000},"page":"663-671","source":"Crossref","is-referenced-by-count":44,"title":["Subjective and neurovegetative changes in healthy volunteers and panic patients performing simulated public speaking"],"prefix":"10.1016","volume":"15","author":[{"given":"Alexandre C.B.V.","family":"Parente","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cybele","family":"Garcia-Leal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina M.","family":"Del-Ben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco S.","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederico G.","family":"Graeff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2005.05.002_bib1","article-title":"Diagnostic and Statistical Manual of Mental Disorders","volume":"IV","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.euroneuro.2005.05.002_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00004850-199506000-00003","article-title":"Assessing the efficacy of treatments for panic disorder and agoraphobia: II. The panic and agoraphobia scale","volume":"10","author":"Bandelow","year":"1995","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2005.05.002_bib3","series-title":"Anxiety and its Disorders: The Nature and Treatment of Anxiety and Panic","author":"Barlow","year":"1988"},{"key":"10.1016\/j.euroneuro.2005.05.002_bib4","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1523\/JNEUROSCI.19-13-05473.1999","article-title":"Different contributions of the human amygdala and vetromedial prefrontal cortex to decision-making","volume":"19","author":"Bechara","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2005.05.002_bib5","series-title":"Cross-Cultural Research on Anxiety","first-page":"29","article-title":"The development and validation of an experimental Portuguese form of the state trait anxiety inventory","author":"Biaggio","year":"1976"},{"key":"10.1016\/j.euroneuro.2005.05.002_bib6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1146\/annurev.ps.39.020188.000355","article-title":"Ethoexperimental approaches to the biology of emotion","volume":"39","author":"Blanchard","year":"1988","journal-title":"Annu. Rev. Psychol."},{"key":"10.1016\/j.euroneuro.2005.05.002_bib7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/BF02193524","article-title":"Psychophysiological and biochemical changes in patients with panic attacks in a defined situational arousal","volume":"244","author":"Braune","year":"1994","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2005.05.002_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0165-0327(99)00140-8","article-title":"Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment","volume":"60","author":"Brunello","year":"2000","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2005.05.002_bib9","series-title":"Bodily Changes in Pain, Hunger, Fear, and Rage","author":"Cannon","year":"1929"},{"key":"10.1016\/j.euroneuro.2005.05.002_bib10","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/archpsyc.1984.01790190025003","article-title":"Noradrenergic function in panic anxiety: effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder","volume":"41","author":"Charney","year":"1984","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.05.002_bib11","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/026988119100500414","article-title":"5-HT and mechanisms of defence","volume":"5","author":"Deakin","year":"1991","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2005.05.002_bib13","series-title":"Proceedings of the World Federation of Societies of Biological Psychiatry Symposium. Clinical Profile of Ritanserin","first-page":"16","article-title":"Early clinical experience with ritanserin in neurotic patients","author":"Deakin","year":"1990"},{"key":"10.1016\/j.euroneuro.2005.05.002_bib12","first-page":"211","article-title":"Testing 5-HT theories of anxiety in normal volunteers","volume":"vol. 1","author":"Deakin","year":"1994"},{"key":"10.1016\/j.euroneuro.2005.05.002_bib14","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1590\/S1516-44462001000300008","article-title":"Confiabilidade teste\u2013reteste da entrevista cl\u00ednica estruturada para o DSM-IV\u2014Vers\u00e3o cl\u00ednica (SCID-CV) traduzida para o Portugu\u00eas","volume":"23","author":"Del-Ben","year":"2001","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.euroneuro.2005.05.002_bib15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0165-1781(01)00312-2","article-title":"Do panic patients process unconditioned fear vs. conditioned anxiety differently than normal subjects?","volume":"104","author":"Del-Ben","year":"2001","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2005.05.002_bib16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF02245749","article-title":"Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin","volume":"102","author":"Den Boer","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2005.05.002_bib17","series-title":"The Midbrain Periaqueductal Gray Matter: Functional, Anatomical and Immunohistochemical Organization","first-page":"151","article-title":"The midbrain periaqueductal gray as a coordinator of action in response to fear and anxiety","author":"Fanselow","year":"1991"},{"key":"10.1016\/j.euroneuro.2005.05.002_bib18","series-title":"Structured Clinical Interview for DSM-IV Axis I Disorders\u2014Clinician Version (SCID-CV)","author":"First","year":"1997"},{"key":"10.1016\/j.euroneuro.2005.05.002_bib19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1469-8986.1980.tb00117.x","article-title":"The three arousal model: implications of Gray's two-factor learning theory for heart rate, electrodermal activity, and psychopathy","volume":"17","author":"Fowles","year":"1980","journal-title":"Psychophysiology"},{"key":"10.1016\/j.euroneuro.2005.05.002_bib20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0165-0327(00)00336-0","article-title":"Electrodermal hyporeactivity and atisocial behavior: does anxiety mediate the relationship?","volume":"61","author":"Fowles","year":"2000","journal-title":"J. Affect. Disord."},{"issue":"Suppl. 1","key":"10.1016\/j.euroneuro.2005.05.002_bib21","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1097\/00004714-199704001-00002","article-title":"Pharmacology of antidepressants","volume":"17","author":"Frazer","year":"1997","journal-title":"J. Clin. Psychopharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.euroneuro.2005.05.002_bib22","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000284079","article-title":"Psychophysiological factors in panic disorder","volume":"17","author":"Freedman","year":"1984","journal-title":"Psychopathology"},{"key":"10.1016\/j.euroneuro.2005.05.002_bib23","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s001270050163","article-title":"Social phobia in the general population: prevalence and sociodemographic profile","volume":"34","author":"Furmark","year":"1999","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.euroneuro.2005.05.002_bib24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.psychres.2004.04.010","article-title":"Anxiety and salivary cortisol in symptomatic and nonsymptomatic panic patients and healthy volunteers performing simulated public speaking","volume":"133","author":"Garcia-Leal","year":"2005","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2005.05.002_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0005-7967(65)90040-9","article-title":"The development of a scale to measure fear","volume":"3","author":"Geer","year":"1965","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.euroneuro.2005.05.002_bib26","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.neubiorev.2003.12.004","article-title":"Serotonin, the periaqueductal gray and panic disorder","volume":"28","author":"Graeff","year":"2004","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2005.05.002_bib27","series-title":"Textbook of Biological Psychiatry","first-page":"879","article-title":"Animal models of anxiety disorders","author":"Graeff","year":"2002"},{"key":"10.1016\/j.euroneuro.2005.05.002_bib28","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1590\/S0100-879X2003000400003","article-title":"Pharmacology of human experimental anxiety","volume":"36","author":"Graeff","year":"2003","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.euroneuro.2005.05.002_bib29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0005-7967(70)90069-0","article-title":"The psychophysiological basis of introversion\u2013extroversion","volume":"8","author":"Gray","year":"1970","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.euroneuro.2005.05.002_bib31","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/026988118700100305","article-title":"Effect of chlorimipramine and maprotiline on experimental anxiety in humans","volume":"1","author":"Guimar\u00e3es","year":"1987","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2005.05.002_bib30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/026988119701100305","article-title":"Ritanserin facilitates anxiety in simulated public-speaking paradigm","volume":"11","author":"Guimar\u00e3es","year":"1997","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2005.05.002_bib32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00004714-199602000-00014","article-title":"Addition of d-fenfluramine to benzodiazepines produces a marked improvement in refractory panic disorder\u2014A case report","volume":"16","author":"Hetem","year":"1996","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2005.05.002_bib33","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/BF02246136","article-title":"Effect of d-fenfluramine on human experimental anxiety","volume":"127","author":"Hetem","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2005.05.002_bib35","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/BF02900305","article-title":"Physiological, biochemical and subjective parameters in anxiety patients with panic disorder during stress exposure as compared with healthy controls","volume":"247","author":"Hoehn","year":"1997","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2005.05.002_bib34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1600-0447.1991.tb05503.x","article-title":"Psychophysiological response patterns in panic disorder","volume":"83","author":"Hoehn-Saric","year":"1991","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2005.05.002_bib36","first-page":"294","article-title":"Escalas de Avalia\u00e7\u00e3o Cl\u00ednica: Transtorno de P\u00e2nico","volume":"25","author":"Ito","year":"1998","journal-title":"Rev. Psiquiatr. Cl\u00edn."},{"key":"10.1016\/j.euroneuro.2005.05.002_bib37","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0091-3057(01)00785-7","article-title":"Chronic imipramine enhances 5-HT(1A) and 5-HT(2) receptors-mediated inhibition of panic-like behavior in the rat dorsal periaqueductal gray","volume":"72","author":"Jacob","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2005.05.002_bib38","first-page":"127","article-title":"Psychophysiology of clinical anxiety","volume":"9","author":"Lader","year":"1975","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.05.002_bib39","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/archpsyc.1985.01790300077010","article-title":"Lactate provocation of panic attacks: biochemical and physiological findings","volume":"42","author":"Liebowitz","year":"1985","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.05.002_bib40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF00436092","article-title":"Simulated public speaking as a model of clinical anxiety","volume":"77","author":"McNair","year":"1982","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2005.05.002_bib41","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.neubiorev.2004.03.005","article-title":"A two-dimensional neuropsychology of defense: fear\/anxiety and defensive distance","volume":"28","author":"McNaughton","year":"2004","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2005.05.002_bib42","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.neuroimage.2004.01.019","article-title":"Activity in ventromedial prefrontal cortex covaries with sympathetic skin conductance level: a physiological account of a \u201cdefault mode\u201d of brain function","volume":"22","author":"Nagai","year":"2004","journal-title":"NeuroImage"},{"key":"10.1016\/j.euroneuro.2005.05.002_bib43","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0028-3908(71)90039-6","article-title":"The action of sedatives on brainstem oculomotor systems in man","volume":"10","author":"Norris","year":"1971","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2005.05.002_bib44","first-page":"2895","article-title":"Anxiety induced by simulated public speaking and stroop colour word test in healthy subjects: effects of different trait-anxiety levels","volume":"27","author":"Palma","year":"1994","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.euroneuro.2005.05.002_bib45","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0887-6185(97)00007-8","article-title":"Normative data for the personal report of confidence as a speaker","volume":"11","author":"Phillips","year":"1997","journal-title":"J. Anxiety Disord."},{"key":"10.1016\/j.euroneuro.2005.05.002_bib48","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/0006-3223(86)90221-0","article-title":"Autonomic characteristics of agoraphobia with panic attacks","volume":"21","author":"Roth","year":"1986","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.05.002_bib47","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0165-1781(88)90145-X","article-title":"Autonomic changes after treatment of agoraphobia with panic attacks","volume":"24","author":"Roth","year":"1988","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2005.05.002_bib46","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-1781(98)00066-3","article-title":"Autonomic instability during relaxation in panic disorder","volume":"80","author":"Roth","year":"1998","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2005.05.002_bib49","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s002130100752","article-title":"Opposed effects of nefazodone in two human models of anxiety","volume":"156","author":"Silva","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2005.05.002_bib50","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1176\/ajp.151.4.621b","article-title":"Controlling panic attacks with fenfluramine","volume":"151","author":"Solyom","year":"1994","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.05.002_bib51","series-title":"Manual for the State-Trait Anxiety Inventory","author":"Spielberger","year":"1970"},{"key":"10.1016\/j.euroneuro.2005.05.002_bib52","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1176\/ajp.151.3.408","article-title":"Setting diagnostic thresholds for social phobia: considerations from a community survey of social anxiety","volume":"151","author":"Stein","year":"1994","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.05.002_bib53","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/archpsyc.1996.01830020087010","article-title":"Public-speaking fears in a community sample. Prevalence, impact on functioning, and diagnostic classification","volume":"53","author":"Stein","year":"1996","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.05.002_bib54","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/archpsyc.1987.01800160077010","article-title":"Situational panic attacks: behavioral, physiologic and biochemical characterization","volume":"44","author":"Woods","year":"1987","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.05.002_bib55","first-page":"403","article-title":"Estudo transcultural de uma escala de auto-avalia\u00e7\u00e3o para estados subjetivos","volume":"131","author":"Zuardi","year":"1981","journal-title":"J. Bras. Psiquiatria"},{"key":"10.1016\/j.euroneuro.2005.05.002_bib56","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/026988119300700112","article-title":"Effects of ipsapirone and cannabidiol on human experimental anxiety","volume":"7","author":"Zuardi","year":"1993","journal-title":"J. Psychopharmacol."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X05000854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X05000854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T12:15:10Z","timestamp":1551096910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X05000854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0924977X05000854"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2005.05.002","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}